Benartärsjukdom - inget nytt sedan SBU-rapporten
Sammanfattning
In 2007 a report on leg ischemia was published by SBU (Board of Health Technology Assessment in Sweden). This paper summarizes the results of this report and analyzes further investigations of interest. No new open surgical or endovascular methods have been reported. Cilostazol has been approved to increase the walking distance in claudicants. Ongoing trials are evaluating the effect of stem cells and angiogenic factors to treat critical limb ischaemia.